Safety of an immune-enhancing nutrition supplement in cirrhotic patients with history of encephalopathy

Journal of Parenteral and Enteral Nutrition

Volumn 30, Issue 2, 2006, Pages 91-96

  Abou Assi, Souheil G ^a,b   Mihas, Anastasios A ^a   Gavis, Edith A ^a   Gilles, HoChong S ^a   Haselbush, Amy ^a   Levy, James R ^a   Habib, Adil ^a   Heuman, Douglas M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Gastrointestinal Specialists Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LACTULOSE; NUTRACEUTICAL; PEPTIDE YY; TRANSFERRIN;

ADULT; AMMONIA BLOOD LEVEL; ANAMNESIS; ARTICLE; CHOLECYSTECTOMY; CLINICAL ARTICLE; COGNITIVE DEFECT; DEATH; DIET RESTRICTION; DIET SUPPLEMENTATION; DISEASE SEVERITY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HEPATIC ENCEPHALOPATHY; HUMAN; INGESTION; INSULIN BLOOD LEVEL; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MALNUTRITION; NUTRIENT SOLUTION; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PALATABILITY; PRIORITY JOURNAL; PSYCHOMETRY; SAFETY; SCORING SYSTEM; TRANSFERRIN BLOOD LEVEL; ALCOHOL LIVER CIRRHOSIS; BLOOD; BRAIN DISEASE; HEPATITIS B; HEPATITIS C; IMMUNITY; MIDDLE AGED; TIME;

ADULT; AMMONIA; BRAIN DISEASES; DIETARY SUPPLEMENTS; FASTING; HEPATITIS B; HEPATITIS C; HUMANS; IMMUNITY; INSULIN; LIVER CIRRHOSIS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; PEPTIDE YY; TIME FACTORS; TRANSFERRIN;

EID: 33745490910     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/014860710603000291     Document Type: Article

References (38)

1. Koretz RL. Immunonutrition: fact, fantasy, and future. Curr Gastroenterol Rep. 2002;4:332-337.
2. Tashiro T. N-3 polyunsaturated fatty acids in pharmaconutrition and immunonutrition [abstract]. J Gastroenterol. 2000;35(suppl 12):24.
3. Efron D, Barbul A. Role of arginine in immunonutrition. J Gastroenterol. 2000;35(suppl 12):20-23.
4. Alexander JW. Immunonutrition: the role of omega-3 fatty acids. Nutrition. 1998;14:627-633.
5. Grimble RF, Grimble GK. Immunonutrition: role of sulfur amino acids, related amino acids, and polyamines. Nutrition. 1998;14: 605-610.
6. Saffle JR, Wiebke G, Jennings K, Morris SE, Barton RG. Randomized trial of immune-enhancing enteral nutrition in burn patients. J Trauma. 1997;42:793-800.
7. Beale RJ, Bryg DJ, Bihari DJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med. 1999; 27:2799-2805.
8. Nutritional status in cirrhosis. Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis. J Hepatol. 1994;21:317-325.
9. Teran JC. Nutrition and liver diseases. Curr Gastroenterol Rep. 1999;1:335-340.
10. Plauth M, Schutz ET. Cachexia in liver cirrhosis. Int J Cardiol. 2002;85:83-87.
11. Crawford DH, Cuneo RC, Shepherd RW. Pathogenesis and assessment of malnutrition in liver disease. J Gastroenterol Hepatol. 1993;8:89-94.
12. Alberino F, Gatta A, Amodio P, et al. Nutrition and survival in patients with liver cirrhosis. Nutrition. 2001;17:445-450.
13. Matos C, Porayko MK, Francisco-Ziller N, DiCecco S. Nutrition and chronic liver disease. J Clin Gastroenterol. 2002;35:391-397.
14. Stephenson GR, Moretti EW, El-Moalem H, Clavien PA, Tuttle-Newhall JE. Malnutrition in liver transplant patients: preoperative subjective global assessment is predictive of outcome after liver transplantation. Transplantation. 2001;72:666-670.
15. Plevak DJ, DiCecco SR, Wiesner RH, et al. Nutritional support for liver transplantation: identifying caloric and protein requirements. Mayo Clinic Proc. 1994;69:225-230.
16. Porayko MK, DiCecco S, O'Keefe SJ. Impact of malnutrition and its therapy on liver transplantation. Semin Liver Dis. 1991;11: 305-314.
17. Harris RA, Benedict FC. A Biometric Study of Basal Metabolism in Man. Washington, DC: Carnegie Institute; 1919. Publication no. 279 ed.
18. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34:768-773.
19. Hasse J, Strong S, Gorman MA, Liepa G. Subjective global assessment: alternative nutrition-assessment technique for liver-transplant candidates. Nutrition. 1993;9:339-343.
20. Pemberton C, Moxness KGM, et al. Mayo Clinic Diet Manual. 6th ed. Toronto: BC Decker; 1988.
21. Pirlich M, Schutz T, Spachos T, et al. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology. 2000;32: 1208-1215.
22. Hosoda H, Kojima M, Mizushima T, Shimizu S, Kangawa K. Structural divergence of human ghrelin: identification of multiple ghrelin-derived molecules produced by post-translational processing. J Biol Chem. 2003 3;278:64-70.
23. Batterham RL, Cowley MA, Small CJ, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 2002; 418:650-654.
24. LeGall-Salmon E, Stevens WD, Levy JR. Total parenteral nutrition increases serum leptin concentration in hospitalized, under-nourished patients. JPEN J Parenter Enteral Nutr. 1999;23:38-42.
25. van der Linden MW, Huizinga TW, Stoeken DJ, Sturk A, Westendorp RG. Determination of tumour necrosis factor-alpha and interleukin-10 production in a whole blood stimulation system: assessment of laboratory error and individual variation. J Immunol Methods. 1998;218:63-71.
26. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464-470.
27. Merli M, Riggio O, Dally L. Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi). Hepatology. 1996;23:1041-1046.
28. Roongpisuthipong C, Sobhonslidsuk A, Nantiruj K, Songchitsomboon S. Nutritional assessment in various stages of liver cirrhosis. Nutrition. 2001;17:761-765.
29. Ziser A, Plevak DJ, Wiesner RH, Rakela J, Offord KP, Brown DL. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology. 1999;90:42-53.
30. Le Cornu KA, McKiernan FJ, Kapadia SA, Neuberger JM. A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantation. Transplantation. 2000;69:1364-1369.
31. Plank L, McCall J, Gane EJ, et al. Safety of pre- and post-operative immunonutrition in patients undergoing liver transplantation: a pilot study of safety and efficacy. Clin Nutr. 2005; 24:288-296.
32. Clarke S, Bernal W, Rees G, Wendon J. Immunonutrition in critically ill patients with liver disease: a prospective randomized double-blind controlled trial [abstract]. Hepatology. 2004;40: 773A.
33. Ferenci P, Wewalka F. Plasma amino acids in hepatic encephalopathy. J Neural Transm Suppl. 1978;14:87-94.
34. Mizock BA. Nutritional support in hepatic encephalopathy. Nutrition. 1999;15:220-228.
35. Douglass A, Al MH, Record CO. Oral tryptophan challenge studies in cirrhotic patients: no evidence of neuropsychiatric changes. Metab Brain Dis. 2003;18:179-186.
36. Masini A, Efrati C, Merli M, et al. Effect of blood ammonia elevation following oral glutamine load on the psychometric performance of cirrhotic patients. Metab Brain Dis. 2003;18:27-35.
37. Ukkola O. Peripheral regulation of food intake: new insights. J Endocrinol Invest. 2004;27:96-98.
38. Choudhury J, Sanyal AJ. Clinical aspects of fatty liver disease. Semin Liver Dis. 2004;24:349-362.